About Infinity Bio
Infinity Bio is a private company based in Baltimore, Maryland, incorporated in 2023 in United States. It has reported $11,516,093 raised in three offerings on Form D since June 2023. Its chief executive is Joy Nassif.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 13, 2025 | Aug 20, 2025 | $5,000,000of $7.0M target | 1 | $5.0M | Equity, Preferred Stock can convert to Common Stock.Rule 506(b) | Form D ↗ |
| Feb 18, 2025 | Mar 11, 2025 | $2,000,000of $5.0M target | 2 | $1.0M | Debt, Debt can convert to equity.Rule 506(b) | Form D ↗ |
| Jun 16, 2023 | Jun 26, 2023amended Jun 3, 2024 | $4,516,093fully sold | 1 | $4.5M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, three offerings | $11,516,093 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Infinity Bio's Form D filed Aug 20, 2025.
BC
Bill Campbell
Director
CP
Caroline Popper
Director
MF
Malek Fahem
Director
HL
H. Larman
Executive officer and director
HS
Herman Scholtz
Director
MH
Matthew Hellauer
Director
JN
Joy Nassif
Chief Executive Officer and director
Earlier filings also listed Benjamin Larman (executive officer and director, last listed Mar 2025).